Skip to content

Author

Patricia A. Pellikka

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 18296: Association of SGLT2 Inhibitor Therapy with Long-Term Outcomes Following Aortic Valve Replacement: A Danish Registry Analysis

Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have emerged as an important therapy for heart failure and have favorable effects on myocardial remodeling, fibrosis, and inflammation. The overlap between aortic stenosis (AS) and heart failure with preserved ejection fraction provides a rationale for e...

M. Hamandi, L. Krasniqi, P. Mortensen et al. · 0 citations
Oct 2026

GLP-1 receptor agonist treatment and cardiovascular outcomes following aortic valve replacement: a nationwide observational study.

BACKGROUND GLP-1 receptor agonists reduce major adverse cardiovascular events among patients with diabetes, overweight, and obesity. Whether these benefits extend to patients undergoing aortic valve replacement (AVR) for severe aortic stenosis (AS) remains unknown. Thus, we investigated the association between GLP-1 re...

L. Krasniqi, M. Hamandi, P. Mortensen et al. · 0 citations
Sep 2026

Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study.

Addition of LA strain imaging with optimized rule-in or rule-out values improves diagnostic triage by expanding non-invasive rule-in/rule-out classifications while identifying patients who still require invasive testing in the evaluation of HFpEF.

T. Harada, Yogesh N. V. Reddy, H. Sorimachi et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.